US XPRESS ENTERPRISES INC -A (USX) Fundamental Analysis & Valuation

NYSE:USX • US90338N2027

Current stock price

6.14 USD
0 (0%)
At close:
6.14 USD
0 (0%)
After Hours:

This USX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. USX Profitability Analysis

1.1 Basic Checks

  • In the past year USX has reported negative net income.
  • In the past year USX had a positive cash flow from operations.
USX Yearly Net Income VS EBIT VS OCF VS FCFUSX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 0 100M -100M

1.2 Ratios

  • The profitability ratios for USX are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
USX Yearly ROA, ROE, ROICUSX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 20 40

1.3 Margins

  • USX has a better Gross Margin (61.79%) than 72.50% of its industry peers.
  • USX's Gross Margin has declined in the last couple of years.
  • USX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.79%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.29%
GM growth 5Y-1.85%
USX Yearly Profit, Operating, Gross MarginsUSX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. USX Health Analysis

2.1 Basic Checks

  • USX does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for USX has been increased compared to 1 year ago.
  • The debt/assets ratio for USX is higher compared to a year ago.
USX Yearly Shares OutstandingUSX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M
USX Yearly Total Debt VS Total AssetsUSX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 200M 400M 600M 800M 1B

2.2 Solvency

  • USX has an Altman-Z score of 1.44. This is a bad value and indicates that USX is not financially healthy and even has some risk of bankruptcy.
  • USX has a worse Altman-Z score (1.44) than 72.50% of its industry peers.
  • A Debt/Equity ratio of 1.79 is on the high side and indicates that USX has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.79, USX is not doing good in the industry: 67.50% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Altman-Z 1.44
ROIC/WACCN/A
WACC8.23%
USX Yearly LT Debt VS Equity VS FCFUSX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 200M 400M

2.3 Liquidity

  • A Current Ratio of 0.71 indicates that USX may have some problems paying its short term obligations.
  • USX has a Current ratio of 0.71. This is in the lower half of the industry: USX underperforms 77.50% of its industry peers.
  • USX has a Quick Ratio of 0.71. This is a bad value and indicates that USX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • USX has a worse Quick ratio (0.69) than 72.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.71
Quick Ratio 0.69
USX Yearly Current Assets VS Current LiabilitesUSX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. USX Growth Analysis

3.1 Past

  • USX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1220.00%.
  • The Revenue has been growing slightly by 6.04% in the past year.
  • Measured over the past years, USX shows a small growth in Revenue. The Revenue has been growing by 6.80% on average per year.
EPS 1Y (TTM)-1220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2450%
Revenue 1Y (TTM)6.04%
Revenue growth 3Y8.17%
Revenue growth 5Y6.8%
Sales Q2Q%-4.73%

3.2 Future

  • USX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 47.15% yearly.
  • The Revenue is expected to grow by 3.65% on average over the next years.
EPS Next Y11.56%
EPS Next 2Y47.89%
EPS Next 3Y47.15%
EPS Next 5YN/A
Revenue Next Year-2.35%
Revenue Next 2Y1.33%
Revenue Next 3Y3.65%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
USX Yearly Revenue VS EstimatesUSX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
USX Yearly EPS VS EstimatesUSX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

1

4. USX Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for USX. In the last year negative earnings were reported.
  • With a Price/Forward Earnings ratio of 52.11, USX can be considered very expensive at the moment.
  • Based on the Price/Forward Earnings ratio, USX is valued a bit more expensive than the industry average as 67.50% of the companies are valued more cheaply.
  • The average S&P500 Price/Forward Earnings ratio is at 23.54. USX is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 52.11
USX Price Earnings VS Forward Price EarningsUSX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100

4.2 Price Multiples

  • USX's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. USX is more expensive than 72.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 26.23
USX Per share dataUSX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates USX does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as USX's earnings are expected to grow with 47.15% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y47.89%
EPS Next 3Y47.15%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. USX Dividend Analysis

5.1 Amount

  • No dividends for USX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

USX Fundamentals: All Metrics, Ratios and Statistics

US XPRESS ENTERPRISES INC -A

NYSE:USX (6/30/2023, 8:04:00 PM)

After market: 6.14 0 (0%)

6.14

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryGround Transportation
Earnings (Last)05-10
Earnings (Next)08-01
Inst Owners2.55%
Inst Owner Change-93.88%
Ins Owners2.58%
Ins Owner Change0%
Market Cap331.91M
Revenue(TTM)2.14B
Net Income(TTM)-62.21M
Analysts50
Price Target4.74 (-22.8%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-67.83%
Min EPS beat(2)-100.64%
Max EPS beat(2)-35.01%
EPS beat(4)0
Avg EPS beat(4)-169.34%
Min EPS beat(4)-334.1%
Max EPS beat(4)-35.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-3.07%
Max Revenue beat(2)0.88%
Revenue beat(4)2
Avg Revenue beat(4)-0.64%
Min Revenue beat(4)-3.07%
Max Revenue beat(4)0.88%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)40.2%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.77%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.47%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 52.11
P/S 0.16
P/FCF N/A
P/OCF 7.25
P/B 1.56
P/tB 2.55
EV/EBITDA 26.23
EPS(TTM)-1.12
EYN/A
EPS(NY)0.12
Fwd EY1.92%
FCF(TTM)-2.78
FCFYN/A
OCF(TTM)0.85
OCFY13.8%
SpS39.53
BVpS3.94
TBVpS2.41
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.79%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.29%
GM growth 5Y-1.85%
F-Score4
Asset Turnover1.58
Health
Industry RankSector Rank
Debt/Equity 1.79
Debt/FCF N/A
Debt/EBITDA 16.14
Cap/Depr 222.01%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.71
Quick Ratio 0.69
Altman-Z 1.44
F-Score4
WACC8.23%
ROIC/WACCN/A
Cap/Depr(3y)226.34%
Cap/Depr(5y)218.67%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1220%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2450%
EPS Next Y11.56%
EPS Next 2Y47.89%
EPS Next 3Y47.15%
EPS Next 5YN/A
Revenue 1Y (TTM)6.04%
Revenue growth 3Y8.17%
Revenue growth 5Y6.8%
Sales Q2Q%-4.73%
Revenue Next Year-2.35%
Revenue Next 2Y1.33%
Revenue Next 3Y3.65%
Revenue Next 5YN/A
EBIT growth 1Y-652.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year611.66%
EBIT Next 3Y131.85%
EBIT Next 5YN/A
FCF growth 1Y-1114.43%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-68.64%
OCF growth 3Y-27.8%
OCF growth 5Y-12.64%

US XPRESS ENTERPRISES INC -A / USX Fundamental Analysis FAQ

What is the ChartMill fundamental rating of US XPRESS ENTERPRISES INC -A (USX) stock?

ChartMill assigns a fundamental rating of 2 / 10 to USX.


Can you provide the valuation status for US XPRESS ENTERPRISES INC -A?

ChartMill assigns a valuation rating of 1 / 10 to US XPRESS ENTERPRISES INC -A (USX). This can be considered as Overvalued.


What is the profitability of USX stock?

US XPRESS ENTERPRISES INC -A (USX) has a profitability rating of 1 / 10.


What is the earnings growth outlook for US XPRESS ENTERPRISES INC -A?

The Earnings per Share (EPS) of US XPRESS ENTERPRISES INC -A (USX) is expected to grow by 11.56% in the next year.